No Link Seen Between Preop GLP-1 Receptor Agonist Use and Postop Aspiration Pneumonia
By Elana Gotkine HealthDay Reporter
THURSDAY, March 6, 2025 -- Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not associated with short-term postoperative aspiration pneumonia, according to a study published online March 4 in JAMA Network Open.
Yuan-Hsin Chen, M.D., M.P.H., from Massachusetts General Hospital in Boston, and colleagues conducted a retrospective cohort study to examine whether preoperative GLP-1 RA use is associated with postoperative aspiration pneumonia among adult patients undergoing one of 14 common surgical procedures from April 1, 2020, to Sept. 30, 2022. The study included 366,476 patients; 1.6 percent had a preoperative prescription for GLP-1 RA.
The researchers found that compared with nonusers, patients using GLP-1 RAs were more likely to be female (59.0 versus 56.4 percent) and diagnosed with both obesity and diabetes (47.5 versus 6.8 percent). No significant differences were seen in the odds of postoperative pneumonia between GLP-1 RA users and nonusers in an adjusted analysis (odds ratio, 0.78; 95 percent confidence interval, 0.57 to 1.06; P = 0.12).
"In this cohort study, we found no significant association between GLP-1 RA use and increased short-term postoperative aspiration pneumonia," the authors write. "This finding suggests that it may be beneficial to reassess the preoperative withholding guidelines for GLP-1 RAs."
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Low Rates of Isolated Locoregional Recurrence Seen in Young Women With Breast Cancer
TUESDAY, July 29, 2025 -- For women diagnosed with breast cancer at age 40 years or younger, the risk for isolated locoregional recurrence (LRR) is relatively low, according to a...
Perioperative Counseling Reduces Opioid Use After ACL Reconstruction Surgery
TUESDAY, July 29, 2025 -- Opioid-limiting pain management education and counseling reduce opioid consumption with no increase in postoperative pain among patients undergoing...
Risk-Reducing Mastectomy Cost-Effective With Breast Cancer Risk ≥35 Percent
MONDAY, July 28, 2025 -- Undergoing risk-reducing mastectomy (RRM) seems to be cost-effective for women aged 30 to 55 years with a lifetime breast cancer (BC) risk of 35 percent...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.